Cpumycins A–C, aminated benzoic dimers isolated from Streptomyces sp. CPU-W6, demonstrate potential cardioprotective activities and provide promising lead scaffolds for therapeutic development.
Absolute Event Rate: 0% vs 0%
> 620 μM). These findings significantly expand the chemical diversity of shikimate-derived microbial metabolites and provide promising lead scaffolds for the development of therapeutics with potential cardioprotective benefits.
Wang et al. (Tue,) reported a other. Cpumycins A–C, aminated benzoic dimers isolated from Streptomyces sp. CPU-W6, demonstrate potential cardioprotective activities and provide promising lead scaffolds for therapeutic development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: